Publication:
Effects of periodontal and bisphosphonate treatment on the gingival crevicular levels of sclerostin and dickkopf-1 in postmenopausal osteoporosis with and without periodontitis

dc.contributor.authorÖZDEN, FEYZA OTAN
dc.contributor.authorDEMİR, ESRA
dc.contributor.authorLÜTFİOĞLU, MÜGE
dc.contributor.authorAcarel, Elif Eser
dc.contributor.authorBİLGİCİ, BİRŞEN
dc.contributor.authorATMACA, AYŞEGÜL
dc.contributor.institutionauthorDEMİR, ESRA
dc.date.accessioned2022-06-14T20:59:12Z
dc.date.available2022-06-14T20:59:12Z
dc.date.issued2022-06-01T00:00:00Z
dc.description.abstractObjective and Background Both periodontitis and osteoporosis are associated with osteoclast-related bone resorption. Bone metabolism is regulated by wingless-type MMTV integration site family (WNT), and WNT/beta-catenin signals are controlled by physiological antagonists including dickkopf-1 (DKK-1) and sclerostin (SOST). This study examined the effects of periodontal and bisphosphonate (BP) treatment on the gingival crevicular fluid (GCF) sclerostin (SOST) and dickkopf-related protein-1 (DKK-1) levels in osteoporotic and systemically healthy postmenopausal women with and without periodontitis. Materials and Methods A total of 48 postmenopausal women were divided into 4 groups (n = 12) according to periodontal health and osteoporosis status, as follows: Group OP/P: subjects with both osteoporosis and periodontitis; Group P: systemically healthy subjects with periodontitis; Group OP: periodontally healthy subjects with osteoporosis; Group H: systemically and periodontally healthy controls. Clinical data and GCF SOST and DKK-1 levels of the participants were collected at baseline and at 6 and 12 months following the initiation of periodontal and/or BP treatment in the experimental groups. GCF SOST and DKK-1 data were obtained by ELISA. Results Clinical improvements were observed in all experimental groups. GCF SOST and DKK1 baseline levels varied significantly between groups due to periodontal disease (p .05), whereas significant differences were observed between Groups H and P, indicating a deviation from periodontal health in Group P (p < .01). Conclusions Significant changes in GCF SOST and DKK-1 levels were observed among women with osteoporosis who received both periodontal and BP treatment. A more detailed examination of how these treatment protocols can be combined may lead to new therapeutic approaches towards periodontal disease.
dc.identifier.citationÖZDEN F. O. , DEMİR E., LÜTFİOĞLU M., Acarel E. E. , BİLGİCİ B., ATMACA A., -Effects of periodontal and bisphosphonate treatment on the gingival crevicular levels of sclerostin and dickkopf-1 in postmenopausal osteoporosis with and without periodontitis-, JOURNAL OF PERIODONTAL RESEARCH, 2022
dc.identifier.doi10.1111/jre.13023
dc.identifier.pubmed35665506
dc.identifier.scopus85131160600
dc.identifier.urihttp://hdl.handle.net/20.500.12645/30745
dc.identifier.wosWOS:000805790700001
dc.titleEffects of periodontal and bisphosphonate treatment on the gingival crevicular levels of sclerostin and dickkopf-1 in postmenopausal osteoporosis with and without periodontitis
dc.typeArticle
dspace.entity.typePublication
local.avesis.id93f82bbb-0ea0-4d18-8687-249ef7e57e6f
local.indexed.atPubMed
local.indexed.atWOS
local.indexed.atScopus
local.publication.isinternational1
relation.isAuthorOfPublication8e934cfb-12e9-48d1-918c-2638cc60c4a4
relation.isAuthorOfPublication.latestForDiscovery8e934cfb-12e9-48d1-918c-2638cc60c4a4

Files